Form D · Pharmaceuticals

MilanaPharm, LLC

Tallassee, AL · CIK 0001749847

Offering snapshot reported Jan 10, 2019 · SEC filing

Reported sold
$175K
Offering amount: $175K
Investors reported
5
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Aug 1, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$87.5K$175KAug 10, 2018: $20,000.00Aug 10, 2018Jan 10, 2019: $175,000.00Jan 10, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,000 → $175,000
  • Reported investors1 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 10, 2019Amendment$175,000$155,000vs Aug 10, 20185SEC filing
Aug 10, 2018Initial$20,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-318943
Original offering amount was $350,000, however, offering was closed after accepting $175,000.

Source: Form D, filed Jan 10, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James A.H. Harwick Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4 Peachwood Drive
Tallassee, AL, 36078